As a small-cap voice AI enterprise, SoundHound AI continues to draw attention on watchlists. The stock has recently traded under $10 as market participants keep an eye on revenue expansion, client agreements, and the acquisition of LivePerson. For traders monitoring SOUN throughout October, market volatility remains a key factor.
BigBear.ai Targets Government AI Demand
Specializing in decision intelligence tools driven by artificial intelligence, BigBear.ai serves governmental clients alongside other sectors. With shares recently hovering around $2.65, BBAI stays comfortably beneath the $10 threshold. Throughout October, investors are likely to pay closer attention to contract announcements, revenue directions, liquidity requirements, and operational strategies.
Rekor Systems Focuses On Roadway Intelligence
Applying artificial intelligence and computer vision to mobility data, public safety, and roadway intelligence, Rekor Systems stays on the radar as an affordable small-cap entity. Investors will be keeping a close eye on REKR through October by monitoring contract wins, the translation of revenue, capital utilization, and forthcoming corporate updates.
Guardforce AI Expands Smart Technology
By merging traditional security operations with smart solutions and robotics, Guardforce AI positions GFAI as a heavily monitored penny stock trading substantially under $10. Although recent financial reports indicated an increase in first-half revenue, net losses also expanded, turning financial resilience and operational execution into vital considerations.
Veritone Develops Enterprise AI Tools
Veritone creates enterprise-level artificial intelligence applications focusing on sectors such as evidence management and video intelligence. While its stock price stays under $10, market observers are monitoring expense cuts, revenue trajectories, and corporate developments. Given recent financial disclosures, cash management and execution remain essential topics for October.
Lantern Pharma Uses AI In Drug Development
Utilizing its RADR platform, Lantern Pharma focuses on precision oncology and artificial intelligence-driven drug discovery. The equity has recently changed hands at low-dollar values, maintaining LTRN under the $10 mark. Observers tracking the company in October will likely closely follow pipeline advancements, partnership announcements, capital-raising efforts, and clinical progress.
Evolv Technologies Brings AI To Security Screening
Offering artificial intelligence-powered security screening platforms designed for high-traffic venues, Evolv Technologies traded near $4.71 as of September 29, keeping its stock below $10. Throughout October, market participants may closely follow product adoption rates, top-line growth, customer demand, profit margins, and corporate updates.
Join our WhatsApp Channel to get the latest news, exclusives and videos on WhatsApp
